Results 221 to 230 of about 45,806 (246)

Thrombotic Thrombocytopenic Purpura

New England Journal of Medicine, 2019
Thrombotic Thrombocytopenic Purpura A 35-year-old man presented with a 2-day history of abdominal pain and headache. A peripheral-blood smear showed numerous schistocytes, and a diagnosis of thrombotic thrombocytopenic purpura was made.
Shruti Bhandari, Rohit Kumar
openaire   +2 more sources

Thrombotic Thrombocytopenic Purpura

JAMA: The Journal of the American Medical Association, 1991
CASE PRESENTATION —Charles T. Bingham III, MD A 27-YEAR-OLD man was transferred to The Johns Hopkins Hospital for evaluation of delirium. Five days prior to admission he had presented to another hospital with hematemesis and syncope. Esophagogastroduodenoscopy revealed the presence of a 0.5-cm gastric ulcer.
openaire   +3 more sources

Thrombotic thrombocytopenic purpura

The Journal of Maternal-Fetal & Neonatal Medicine, 2012
A 34-year old primipara was admitted to hospital with dichorionic-diamniotic twins in 26+3 weeks of gestation. In suspicion of HELLP-syndrome, caesarean section was performed at 27+4 weeks of gestation, because of platelet count was reduced to 44000/µl. A re-laparotomy had to be performed because of intra-abdominal bleedings.
Anne-Sybil Gast, Ulrich Gembruch, Viktor Janzen, Charlotte Kaiser   +3 more
openaire   +3 more sources

An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

Expert Review of Hematology, 2019
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, consumption thrombocytopenia, and organ injury. TTP pathophysiology is based on a severe
B. Joly, P. Coppo, A. Veyradier
semanticscholar   +1 more source

THROMBOTIC THROMBOCYTOPENIC PURPURA

Medical Journal of Australia, 1957
Abstract 1.1. Three additional cases of thrombotic thrombocytopenic purpura are reported. 2.2. The possibility of diagnosis of this disorder by biopsy of a lymph node selected at random is confirmed. 3.3. Evidence is presented that platelets and megakaryocytes which have passed through the pulmonary circulation are incorporated in the thrombotic ...
openaire   +6 more sources

Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura

Transfusion, 2020
The introduction of therapeutic plasma exchange (TPE) dramatically decreased mortality in patients with immune thrombotic thrombocytopenic purpura (iTTP).
M. Colling, Lova Sun, V. Upadhyay, Justine Ryu, Ang Li, L. Uhl, R. Kaufman, C. Stowell, W. Dzik, R. Makar, Pavan K Bendapudi   +10 more
semanticscholar   +1 more source

THROMBOTIC THROMBOCYTOPENIC PURPURA

Annals of Internal Medicine, 1953
Excerpt Thrombotic thrombocytopenic purpura is a rare disease of which only a few cases have been diagnosed ante mortem.4Because of the rarity of diagnosis, other than at the autopsy table, few lab...
Thomas W. Green, Waverly S. Green
openaire   +3 more sources

The Pathogenesis of Thrombotic Thrombocytopenic Purpura [PDF]

Seminars in Thrombosis and Hemostasis, 1979
The vascular lesions with microthrombi were studied in 12 patients with thrombotic thrombocytopenic purpura (TTP), diagnosed by the characteristic clinical and laboratory findings and confirmed histologically in each case. While defibrination was not observed, and with only minimal changes in the circulating levels of fibrinogen, fibrin degradation ...
openaire   +3 more sources

Thrombotic Thrombocytopenic Purpura

JAMA: The Journal of the American Medical Association, 1982
Though thrombotic thrombocytopenic purpura (TTP) is not a common disorder, having an estimated annual incidence of one per million population, it merits attention.1First, it afflicts those in the prime of life between the third and fourth decade. Second, it generally runs a fulminant course with mortality in excess of 8096.
openaire   +5 more sources

Autoimmunity in Thrombotic Thrombocytopenic Purpura

Seminars in Thrombosis and Hemostasis, 2005
In the last few years, an autoimmune hypothesis for the pathogenesis of thrombotic thrombocytopenic purpura (TTP) has been proposed often, with variable success because of inconsistent supporting data. We are now aware that at least one subgroup of TTP patients does present with pathogenic autoantibodies (i.e, anti-ADAMTS13); this group consequently is
Porta, Camillo, CAPORALI, ROBERTO, MONTECUCCO, CARLOMAURIZIO   +2 more
openaire   +5 more sources